JNJ — JOHNSON & JOHNSON
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Dividends
Measured signals that fired on JNJ
| date | signal | measured base rate |
|---|---|---|
| 2026-08-18 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-08-18 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-30 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-28 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-24 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-26 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-17 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Open-market sale | 15.0K | 263.36 | 4.0M |
| 2026-08-17 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise | 15.0K | 115.67 | 1.7M |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Open-market sale | 102.3K | 261.00 | 26.7M |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Option exercise | 123.3K | 115.67 | 14.3M |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Open-market sale | 21.0K | 262.00 | 5.5M |
| 2026-08-06 | Forminard Elizabeth EVP, Chief Legal Officer | Open-market sale | 9.3K | 257.75 | 2.4M |
| 2026-08-06 | Forminard Elizabeth EVP, Chief Legal Officer | Open-market sale | 6.6K | 255.93 | 1.7M |
| 2026-08-06 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | 9.3K | 131.94 | 1.2M |
| 2026-08-05 | Duato Joaquin CEO and Chairman of the Board | Open-market sale | 42.0K | 258.06 | 10.8M |
| 2026-08-05 | Duato Joaquin CEO and Chairman of the Board | Open-market sale | 6.5K | 258.74 | 1.7M |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 52.2B | 213.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 38.3B | 156.6M |
| STATE STREET CORP | 32.6B | 133.5M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 15.5B | 63.5M |
| JPMORGAN CHASE & CO | 15.3B | 63.1M |
| GEODE CAPITAL MANAGEMENT, LLC | 14.4B | 59.2M |
| MORGAN STANLEY | 10.9B | 44.7M |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 7.7B | 31.6M |
| NORTHERN TRUST CORP | 7.2B | 29.3M |
| BANK OF AMERICA CORP /DE/ | 6.2B | 25.5M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? · 2026-08-23
- Johnson & Johnson names new vice president for litigation - Reuters · 2026-08-21 · Reuters
- Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future · 2026-08-20
- Johnson & Johnson stock holds close to record highs as Q2 2026 earnings and guidance support valuati - Ad-hoc-news.de · 2026-08-20 · Ad-hoc-news.de
- Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgrade · 2026-08-19 · benzinga
- Johnson & Johnson stock pushes toward record highs as Q2 earnings and MedTech win bolster outlook - Ad-hoc-news.de · 2026-08-19 · AD HOC NEWS
Others in Healthcare
Ask the AI about JNJ
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →